Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||||
| Cash income from operating activities | 39.43%678.95K | -59.48%486.94K | 41.48%1.2M | -88.16%849.41K | 125.54%7.17M | 34.27%3.18M | -26.53%2.37M | -72.14%3.22M | 116.37%11.57M | 148.72%5.35M |
| Revenue from customers | --686.46K | ---- | 517.29%123.46K | -99.70%20K | 303.05%6.61M | --1.64M | ---- | -93.92%616.22K | 425.08%10.14M | -6.71%1.93M |
| Income from government grants | ---- | ---- | ---- | --829.41K | ---- | ---- | --6K | ---- | ---- | ---- |
| Other cash income from operating activities | -101.54%-7.51K | -54.84%486.94K | --1.08M | ---- | -63.23%566.75K | -34.76%1.54M | -9.40%2.36M | 82.08%2.61M | -58.08%1.43M | 4,146.53%3.42M |
| Cash paid | -846.09%-5.94M | 64.39%-627.83K | 59.92%-1.76M | 2.75%-4.4M | 4.96%-4.52M | 18.85%-4.76M | 21.35%-5.87M | 6.51%-7.46M | -4.47%-7.98M | 35.84%-7.64M |
| Payments to suppliers for goods and services | -846.09%-5.94M | 64.39%-627.83K | 59.92%-1.76M | 2.75%-4.4M | 4.96%-4.52M | 18.85%-4.76M | 21.35%-5.87M | 6.51%-7.46M | -4.47%-7.98M | 35.84%-7.64M |
| Direct interest paid | -21.00%-18.13K | 84.75%-14.99K | -137.32%-98.27K | 82.13%-41.41K | 31.68%-231.67K | -172.68%-339.1K | -380.85%-124.36K | -59.45%-25.86K | 18.49%-16.22K | 64.11%-19.9K |
| Direct interest received | 589,040.00%29.46K | -87.18%5 | 3,800.00%39 | -91.67%1 | -98.46%12 | -95.91%780 | 43.98%19.08K | 58.87%13.25K | -84.84%8.34K | -64.15%55.02K |
| Operating cash flow | -3,268.02%-5.25M | 76.37%-155.86K | 81.63%-659.66K | -248.48%-3.59M | 226.13%2.42M | 46.86%-1.92M | 15.04%-3.61M | -218.39%-4.25M | 259.20%3.59M | 61.96%-2.25M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 19.86%-333.48K | -750.25%-416.13K | -478.10%-48.94K | -8.76%-8.47K | -148.10%-7.78K | 312.36%16.18K | 94.95%-7.62K | 33.63%-150.97K | 1.49%-227.46K | -188.54%-230.9K |
| Net PPE purchase and sale | ---5.25K | ---- | 430.44%27.98K | -8.76%-8.47K | -243.35%-7.78K | 171.26%5.43K | 94.95%-7.62K | -7.56%-150.97K | 39.22%-140.35K | -24.96%-230.9K |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | --10.75K | ---- | ---- | ---- | ---- |
| Net investment purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---87.11K | ---- |
| Net other investing changes | 21.12%-328.23K | -441.01%-416.13K | ---76.92K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 19.86%-333.48K | -750.25%-416.13K | -478.10%-48.94K | -8.76%-8.47K | -148.10%-7.78K | 312.36%16.18K | 94.95%-7.62K | 33.63%-150.97K | 1.49%-227.46K | -188.54%-230.9K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -8.09%2.88M | 242.06%3.13M | 1,036.54%916.27K | -124.46%-97.84K | -84.78%400K | -5.48%2.63M | 105.25%2.78M | 448.96%1.35M | 246.73K | |
| Net issuance payments of debt | ---- | -163.44%-347.02K | 308.23%547.02K | 76.12%-262.7K | 14.06%-1.1M | -146.04%-1.28M | 105.25%2.78M | --1.35M | --0 | ---- |
| Net common stock issuance | -17.25%2.88M | 11,421.23%3.48M | ---30.75K | ---- | -61.36%1.5M | --3.88M | ---- | ---- | ---- | ---- |
| Net other financing activities | ---- | ---- | -118.65%-30.75K | --164.87K | ---- | --25.93K | ---- | ---- | --246.73K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -8.09%2.88M | 242.06%3.13M | 1,036.54%916.27K | -124.46%-97.84K | -84.78%400K | -5.48%2.63M | 105.25%2.78M | 448.96%1.35M | --246.73K | ---- |
| Net cash flow | ||||||||||
| Beginning cash position | 846.18%2.86M | 218.32%302.79K | -97.49%95.12K | 286.28%3.79M | 284.34%981.85K | -76.60%255.46K | -73.60%1.09M | 682.18%4.14M | -82.45%528.67K | 20.15%3.01M |
| Current changes in cash | -205.47%-2.7M | 1,133.78%2.56M | 105.62%207.67K | -231.55%-3.7M | 286.97%2.81M | 186.88%726.38K | 72.53%-836.12K | -184.39%-3.04M | 245.18%3.61M | -591.60%-2.48M |
| Effect of exchange rate changes | --3.76K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| End cash Position | -94.19%166.41K | 846.19%2.86M | 218.32%302.79K | -97.49%95.12K | 286.28%3.79M | 284.34%981.85K | -76.60%255.46K | -73.60%1.09M | 682.18%4.14M | -82.45%528.67K |
| Free cash from | -3,271.39%-5.25M | 76.37%-155.86K | 81.67%-659.66K | -249.31%-3.6M | 225.72%2.41M | 46.97%-1.92M | 17.78%-3.62M | -227.95%-4.4M | 237.33%3.44M | 59.18%-2.5M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |